AAAAAA
Results:
1-18
|
Results: 18
Authors:
Galmiche, JP
Zerbib, F
Ducrotte, P
Fournet, J
Rampal, P
Avasthy, N
Humphries, TJ
Citation: Jp. Galmiche et al., Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole, ALIM PHARM, 15(9), 2001, pp. 1343-1350
Authors:
Humphries, TJ
Citation: Tj. Humphries, On gastric polyps, proton pump inhibitors and long-term risks, ALIM PHARM, 15(4), 2001, pp. 559-559
Authors:
Pichard-Garcia, L
Whomsley, R
Daujat, M
Maurel, P
Setoyama, T
Humphries, TJ
Citation: L. Pichard-garcia et al., Comparative effects of rabeprazole and omeprazole on the inducibility of cytochrome P450-1A and cytochrome P450-3A isoenzymes in human hepatocytes, and effects on cyclosporin metabolism in human liver microsomes, CLIN DRUG I, 20(4), 2000, pp. 245-254
Authors:
Ohning, GV
Barbuti, RC
Kovacs, TOG
Sytnik, B
Humphries, TJ
Walsh, JH
Citation: Gv. Ohning et al., Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection, ALIM PHARM, 14(6), 2000, pp. 701-708
Authors:
Thjodleifsson, B
Beker, JA
Dekkers, C
Bjaaland, T
Finnegan, V
Humphries, TJ
Citation: B. Thjodleifsson et al., Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease - A double-blind, multicenter, European trial, DIG DIS SCI, 45(5), 2000, pp. 845-853
Authors:
Humphries, TJ
Citation: Tj. Humphries, Letters to the editor - Dear Dr. Walson, CLIN THER, 22(12), 2000, pp. 1590-1591
Authors:
Delchier, JC
Cohen, G
Humphries, TJ
Citation: Jc. Delchier et al., Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal refluxdisease, SC J GASTR, 35(12), 2000, pp. 1245-1250
Authors:
Farley, A
Wruble, LD
Humphries, TJ
Citation: A. Farley et al., Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: A double-blind, randomized clinical trial, AM J GASTRO, 95(8), 2000, pp. 1894-1899
Authors:
Breiter, JR
Riff, D
Humphries, TJ
Citation: Jr. Breiter et al., Rabeprazole is superior to ranitidine in the management of active duodenalulcer disease: Results of a double-blind, randomized North American study, AM J GASTRO, 95(4), 2000, pp. 936-942
Authors:
Humphries, TJ
Citation: Tj. Humphries, Rabeprazole: Profile of a new proton pump inhibitor - Prologue, ALIM PHARM, 13, 1999, pp. 1-1
Authors:
Humphries, TJ
Barth, J
Citation: Tj. Humphries et J. Barth, Review article: rabeprazole's profile in patients with gastrointestinal diseases, ALIM PHARM, 13, 1999, pp. 25-32
Authors:
Dekkers, CPM
Beker, JA
Thjodleifsson, B
Gabryelewicz, A
Bell, NE
Humphries, TJ
Citation: Cpm. Dekkers et al., Double-blind, comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of erosive or ulcerative gastrooesophageal reflux disease (vol13, pg 49, 1999), ALIM PHARM, 13(4), 1999, pp. 567-567
Authors:
Sachs, G
Humphries, TJ
Citation: G. Sachs et Tj. Humphries, Rabeprazole: Pharmacology, pharmacokinetics, and potential for drug interactions - Introduction, ALIM PHARM, 13, 1999, pp. 1-2
Authors:
Humphries, TJ
Merritt, GJ
Citation: Tj. Humphries et Gj. Merritt, Review article: drug interactions with agents used to treat acid-related diseases, ALIM PHARM, 13, 1999, pp. 18-26
Authors:
Dekkers, CPM
Beker, JA
Thjodleifsson, B
Gabryelewicz, A
Bell, NE
Humphries, TJ
Citation: Cpm. Dekkers et al., Comparison of rabeprazole 20mg versus omeprazole 20mg in the treatment of active duodenal ulcer: a European multicentre study, ALIM PHARM, 13(2), 1999, pp. 179-186
Authors:
Dekkers, CPM
Beker, JA
Thjodleifsson, B
Gabryelewicz, A
Bell, NE
Humphries, TJ
Citation: Cpm. Dekkers et al., Double-blind, placebo-controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease, ALIM PHARM, 13(1), 1999, pp. 49-57
Authors:
Hoyumpa, AM
Trevino-Alanis, H
Grimes, I
Humphries, TJ
Citation: Am. Hoyumpa et al., Rabeprazole: Pharmacokinetics in patients with stable, compensated cirrhosis, CLIN THER, 21(4), 1999, pp. 691-701
Authors:
Keane, WF
Swan, SK
Grimes, I
Humphries, TJ
Citation: Wf. Keane et al., Rabeprazole: Pharmacokinetics and tolerability in patients with stable, end-stage renal failure, J CLIN PHAR, 39(9), 1999, pp. 927-933
Risultati:
1-18
|